Total Synthesis - Partly Including the 3D-Assignments of Hitherto Unknown Stereocenters - of 3-(Polyenoyl)tetramic Acid and 3 (Polyenoyl)hydroxypyridone Natural Products: Militarinones, Farinosone B, Fumosorinone, and two Anomeric Aurantosides

3-(多烯酰基)四酸和3(多烯酰基)羟基吡啶酮天然产物的全合成 - 部分包括迄今为止未知的立体中心的3D分配

基本信息

项目摘要

Tetramic acids are 5-membered ketolactams, active methylene-compounds, and weak acids (pKa 6.4). 3-(Polyenoyl)tetramic acids are active methine-compounds and stronger acids (pKa 3.4). Four natural compounds of the latter type belong to our synthetic goals. Moreover, we plan to synthesize analogous 6-membered ketolactam natural products (five targets) and model compounds (two targets), each with a 3-polyenoyl group. These compounds shall be aromatic or non-aromatic and display an N-H or N-OH motif. They can be binned as 3-(polyenoyl)hydroxypyridones.3-(Polyenoyl) tetramic acids are antibiotics, antivirals, cytotoxics and/or fungicides. This makes them relevant for pharmacy and crop protection. 3-(Polyenoyl)hydroxypyridones affect signal transduction in the nervous system. Therefore, they represent leads for the chemotherapy of diseases destroying nerve cells (Alzheimer's, Parkinson's, injuries of th spinal cord).A main objective of ours is (continuing) the development of efficient synthetic methodology. Firstly, bromoolefin-containing ß-ketothioesters shall be the central trifunctional building block both of 3-(polyenoyl)tetramic acids and hydroxypyridones. We feel encouraged in this regard by the first-time use of such a building block in our structure-elucidating total synthesis of the 3-(polyenoyl)tetramic acids a- and ß-lipomycin. Secondly, the heterocycle of both target molecule groups shall result from Dieckmann condensations. Reaching 5-membered acylketolactames thereby from ß-ketoacylated a-amino acid esters is well-known. In contrast, reaching 6-membered acylketolactames thereby from ß-ketoacylated ß-amino- or ß-(hydroxyamino)acid esters is much less studied. Moreover, certain ß-(hydroxyamino)acid esters shall be prepared from isoxazolidinones. Containing the motif C(= O)-O-N, the latter are no cyclic Weinreb amides. Virtually nothing is known about their enolate chemistry. Just it might serve our objectives well, though.Another main objective is establishing or completing the 3D structure of the seven target molecules, whose configurations are not (fully) known. For elucidating them, we intend to synthesize enantiomerically pure diastereomers of each such compound in such numbers that the absolute value of the specific rotation of one diastereomer must equal the published value. Comparing signs of rotation will then yield the configuration.The militarinones A-C and D-E suggest to have the configuration of their methylated stereocenters clarified by degrading hteir trienoyl side-chain under Lemieux-Johnson conditions. This should deliver alcohols with a syn-oriented pair of methyl groups. Their stereostructure should yield to GC comparisons with pairs of enantiomorphic reference samples (which, in turn, shall stem from synthetis). We acquired expertise in the underlying techniques when cultivating Streptomyces, isolating a-lipomycin, degrading it oxidatively, and GC-ing the resulting alcohols after (trifluoroacetyl)ation.
四酸是5元的酮分酰胺,活性亚甲基化合物和弱酸(PKA 6.4)。 3-(多烯酰)四酸是活性的甲酸化合物和较强的酸(PKA 3.4)。后一种天然化合物属于我们的合成目标。此外,我们计划合成类似的6元酮分酰胺天然产物(五个靶标)和模型化合物(两个靶标),每个产品都有一个3-溶烯酰基。这些化合物应为芳香或非芳香族,并显示N-H或N-OH基序。它们可以被归为3-(元烯酰基)羟基吡啶酮。3-(polyenoyl)四酸是抗生素,抗病毒药,细胞毒素和/或杀真菌的。这使它们与药房和作物保护相关。 3-(聚烯酰)羟型吡啶酮会影响神经系统的信号转导。因此,它们代表了破坏神经细胞的疾病的化疗(阿尔茨海默氏症,帕金森氏症,脊髓损伤)。我们的主要目的是(继续)有效的合成方法的发展。首先,含有溴化的β-酮硫硫代植物应为中央三功能构建块,这是3(polyenoyl)的四酸和羟基吡啶酮的中央构件。在这方面,通过首次使用这种构建块在我们结构培养的3-(polyenoyl)四酸A-和ß-脂肪霉素的总合成中,我们感到鼓舞。其次,两个靶分子基的杂环应由迪克曼凝结产生。从ß-酮酰化的A-氨基酸酯中达到5元的酰基酮乳酸菌是众所周知的。相比之下,从ß-酮酰化β-氨基或ß-(羟基氨基)酸酯酸酯酸酯酸酯的研究较少得多,从而达到6元的酰基酮分型。此外,某些β-(羟基氨基)酸酯应由异恶唑烷酮制备。包含基序C(= o)-O-N,后者无环状膜酰胺。实际上,他们的化学融化一无所知。不过,它可能会很好地实现我们的目标。另一个主要目标是建立或完成七个目标分子的3D结构,其构型尚不清楚。为了阐明它们,我们打算以这样的数字合成每个这样化合物的对映体纯映体,以至于一个非对映异构体的特定旋转的绝对值必须等于已发表的值。然后,比较旋转的迹象将产生配置。MileitaronesA-C和D-E建议通过在Lemieux-Johnson条件下降解HTEIR Trienoyl侧链来阐明其甲基化的立体中心的构型。这应该用面向同步的甲基甲基含量。它们的立体结构应与对对映射的参考样品对(反过来源自合成)进行GC比较。我们在培养链霉菌,分离脂肪霉素,氧化降解并在(trifluoroacetyl)之后添加氧化的氧化剂时获得了潜在技术的专业知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Professor Dr. Rein...的其他基金

Efficient Syntheses of Natural and Unnatural Benzotropolones and Pulvinones. Total Synthesis of the Fungal Dye Aurantricholone
天然和非天然苯并托酚酮和普维酮的高效合成。
  • 批准号:
    277682607
    277682607
  • 财政年份:
    2015
  • 资助金额:
    --
    --
  • 项目类别:
    Research Grants
    Research Grants
Hybrid Molecules From Benzylguanidine and Cytotoxic Drugs (Busulfan, Melphalan, Thiotepa) for Specific Therapy of Neuroblastoma
苄基胍和细胞毒性药物(白消安、美法仑、噻替派)的混合分子用于神经母细胞瘤的特异性治疗
  • 批准号:
    281453513
    281453513
  • 财政年份:
    2015
  • 资助金额:
    --
    --
  • 项目类别:
    Research Grants
    Research Grants
Desymmetrization of Prochiral Sulfoxides: A Novel Asymmetric Synthesis of Sulfoxides
前手性亚砜的去对称化:亚砜的新型不对称合成
  • 批准号:
    252159727
    252159727
  • 财政年份:
    2014
  • 资助金额:
    --
    --
  • 项目类别:
    Research Grants
    Research Grants
Totalsynthese natürlicher und unnatürlicher Carotinoid-Butenolide: Peridinin, Pyrrhoxanthin und Modellchromophore des Lichtsammel-Chromoproteins aus Amphidinium carterae
天然和非天然类胡萝卜素丁烯内酯的全合成:多甲素、吡咯黄素和来自 Amphidinium carterae 的光捕获色蛋白的模型发色团
  • 批准号:
    5284654
    5284654
  • 财政年份:
    2000
  • 资助金额:
    --
    --
  • 项目类别:
    Research Grants
    Research Grants

相似国自然基金

胶质瘤线粒体靶向纳米药物合成及其诱导免疫治疗效应的机制研究
  • 批准号:
    82303810
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
水相液滴化学在污染物分析、中间体监测、有机合成和污染物降解中的应用
  • 批准号:
    22376048
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于非共价键协同效应的受限偶氮均聚物易位合成、组装及性能研究
  • 批准号:
    22361006
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
新骨架紫杉烷二萜baccataxane的化学合成、衍生化和降糖活性研究
  • 批准号:
    82373758
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
大气生物源有机硝酸酯的合成、定量和其在中国南方城市的成因研究
  • 批准号:
    22306059
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Data Driven Discovery of New Catalysts for Asymmetric Synthesis
数据驱动的不对称合成新催化剂的发现
  • 批准号:
    DP240100102
    DP240100102
  • 财政年份:
    2024
  • 资助金额:
    --
    --
  • 项目类别:
    Discovery Projects
    Discovery Projects
Diversity Oriented Clicking - Streamlined Synthesis of Molecular Frameworks
面向多样性的点击——分子框架的简化合成
  • 批准号:
    DE240100449
    DE240100449
  • 财政年份:
    2024
  • 资助金额:
    --
    --
  • 项目类别:
    Discovery Early Career Researcher Award
    Discovery Early Career Researcher Award
軟X線高強度レーザー電場中での共有結合性希ガス分子の形成
软X射线高强度激光电场中共价惰性气体分子的形成
  • 批准号:
    24K15609
    24K15609
  • 财政年份:
    2024
  • 资助金额:
    --
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
    Grant-in-Aid for Scientific Research (C)
Hybrid Electrochemically-paired Light Irradiated Organic Synthesis (Acronym: HELIOS)
混合电化学配对光照射有机合成(缩写:HELIOS)
  • 批准号:
    EP/Y037413/1
    EP/Y037413/1
  • 财政年份:
    2024
  • 资助金额:
    --
    --
  • 项目类别:
    Research Grant
    Research Grant
Harnessing the Power of Diels-Alderases in Sustainable Chemoenzymatic Synthesis
利用 Diels-Alderases 进行可持续化学酶合成
  • 批准号:
    BB/Y000846/1
    BB/Y000846/1
  • 财政年份:
    2024
  • 资助金额:
    --
    --
  • 项目类别:
    Research Grant
    Research Grant